Potential of BPA functionalized poly(vinylalcohol)-shelled perfluorobutane nanodroplets towards enhanced boron neutron capture therapy and in-situ dosimetry
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Boron Compounds in Chemistry · Advanced MRI Techniques and Applications · Atomic and Subatomic Physics Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (70)
Show source-provided references
1. Cancer and radiation therapy: current advances and future directions10.7150/ijms.3635 ↗
2. 1993
3. Boron Analysis and Boron Imaging in BNCT
4. Boron imaging: localized quantitative detection and imaging of boron by magnetic resonance
5. Hawthorne · 2013
6. A novel approach to design and evaluate BNCT neutron beams combining physical, radiobiological, and dosimetric figures of merit
7. 2012
8. The basis and advances in clinical application of boron neutron capture therapy10.1186/s13014-021-01939-7 ↗
9. The development of boron analysis and imaging in boron neutron capture therapy (BNCT)10.1021/acs.molpharmaceut.1c00810 ↗
10. Boron neutron capture therapy: clinical application and research progress10.3390/curroncol29100622 ↗
11. Boron neutron capture therapy: current status and future perspectives10.1002/cac2.12089 ↗
12. Boron neutron capture therapy: a review of clinical applications10.3389/fonc.2021.601820 ↗
13. Boron delivery agents for neutron capture therapy of cancer
14. High and low LET radiation differentially induce normal tissue damage signals10.1016/j.ijrobp.2011.09.057 ↗
15. Detailed dosimetry calculation for in-vitro experiments and its impact on clinical BNCT10.1016/j.ejmp.2021.08.010 ↗
16. Boron neutron capture therapy - a literature review
17. Biodistribution of sodium borocaptate (BSH) for boron neutron capture therapy (BNCT) in an oral cancer model10.1007/s00411-013-0467-8 ↗
18. The therapeutic effects of dodecaborate containing boronophenylalanine for boron neutron capture therapy in a rat brain tumor model
19. Evaluation of pharmacokinetics of boronophenylalanine and its uptakes in gastric cancer10.3389/fonc.2022.925671 ↗
20. Detection of boronic acid derivatives in cells using a fluorescent sensor10.1039/C5OB00753D ↗
21. Boron chemistry for medical applications10.3390/molecules25040828 ↗
22. New candidates for boron carriers in BNCT
23. 2023
24. Hosmane · 2018
25. Boron drug delivery via encapsulated magnetic nanocomposites: a new approach for BNCT in cancer treatment10.1155/2010/409320 ↗
26. Laser-ablative aqueous synthesis and characterization of elemental boron nanoparticles for biomedical applications10.1038/s41598-022-13066-8 ↗
27. Drugs for BNCT: BSH and BPA
28. Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound10.1016/S0140-6736(89)90567-9 ↗
29. Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT210.1111/cas.12602 ↗
30. The l-type amino acid transporter LAT1—an emerging target in cancer10.3390/ijms20102428 ↗
31. Poly(vinyl alcohol) boosting therapeutic potential of p-boronophenylalanine in neutron capture therapy by modulating metabolism10.1126/sciadv.aaz1722 ↗
32. An analysis of the structure of the compound biological effectiveness factor10.1093/jrr/rrw022 ↗
33. Poly(vinyl alcohol) boosting therapeutic potential of p-boronophenylalanine in neutron capture therapy by modulating metabolism
34. Fructose-functionalized polymers to enhance therapeutic potential of p-boronophenylalanine for neutron capture therapy10.1016/j.jconrel.2021.02.021 ↗
35. Poly(vinyl alcohol) as versatile biomaterial for potential biomedical applications10.1023/A:1024907615244 ↗
36. Polyvinyl alcohol based-drug delivery systems for cancer treatment10.1016/j.ijpharm.2021.120478 ↗
37. Next generation ultrasound platforms for theranostics10.1016/j.jcis.2016.12.030 ↗
38. Ultrasound-assisted investigation of photon triggered vaporization of poly(vinylalcohol) phase-change nanodroplets: a preliminary concept study with dosimetry perspective10.1016/j.ejmp.2021.08.006 ↗
39. Microbubble ultrasound contrast agents: a review10.1243/09544110360729072 ↗
40. Phase-change contrast agents for imaging and therapy10.2174/138161212800099883 ↗
41. Optically and acoustically triggerable sub-micron phase-change contrast agents for enhanced photoacoustic and ultrasound imaging10.1016/j.pacs.2017.04.001 ↗
42. Ultrasound-assisted carbon ion dosimetry and range measurement using injectable polymer-shelled phase-change nanodroplets: in vitro study10.1038/s41598-022-11524-x ↗
43. Modulating ultrasound contrast generation from injectable nanodroplets for proton range verification by varying the degree of superheat10.1002/mp.14778 ↗
44. Proton range verification with ultrasound imaging using injectable radiation sensitive nanodroplets: a feasibility study10.1088/1361-6560/ab7506 ↗
45. Spatiotemporal distribution of nanodroplet vaporization in a proton beam using real-time ultrasound imaging for range verification10.1016/j.ultrasmedbio.2021.09.009 ↗
46. The superheated drop detector10.1016/0029-554X(79)90735-3 ↗
47. Fundamental properties of superheated drop (bubble) detectors10.1093/oxfordjournals.rpd.a032796 ↗
48. Phase change dimethyldioctadecylammonium-shelled microdroplets as a promising drug delivery system: results on 3D spheroids of mammalian tumor cells
49. 18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy10.1186/s13550-020-00728-9 ↗
50. Up-regulation of LAT1 during antiandrogen therapy contributes to progression in prostate cancer cells10.1016/j.juro.2015.11.071 ↗
51. Classification and safety of microbubble-based contrast agents
52. 2023
53. Antifolate SERS-active nanovectors: quantitative drug nanostructuring and selective cell targeting for effective theranostics10.1039/C9NR01075K ↗
54. A detailed examination of boronic acid–diol complexation10.1016/S0040-4020(02)00489-1 ↗
55. Structure–reactivity relationships in boronic acid–diol complexation10.1021/acsomega.8b02999 ↗
56. Boric acid cross-linked 3D polyvinyl alcohol gel beads by NaOH-titration method as a suitable biomass immobilization matrix10.1007/s10924-019-01610-z ↗
57. Phenylboronic acid-installed polymeric micelles for targeting sialylated epitopes in solid tumors10.1021/ja406406h ↗
58. Non-isotope enriched phenylboronic acid-decorated dual-functional nano-assembles for an actively targeting BNCT drug10.1016/j.biomaterials.2020.120551 ↗
59. The development of a composite based on cellulose fibres and polyvinyl alcohol in the presence of boric acid10.15376/biores.9.2.3439-3448 ↗
60. Mechanisms of transport of p-borono-phenylalanine through the cell membrane in vitro10.1667/0033-7587(2000)153[0173:MOTOPB]2.0.CO;2 ↗
61. The human SLC7A5 (LAT1): the intriguing histidine/large neutral amino acid transporter and its relevance to human health10.3389/fchem.2018.00243 ↗
62. In vitro and in vivo studies of boron neutron capture therapy: boron uptake/washout and cell death10.1667/RR2156.1 ↗
63. An improved neutron autoradiography set-up for 10B concentration measurements in biological samples10.1016/j.rpor.2015.10.006 ↗
64. Acoustically responsive polydopamine nanodroplets: a novel theranostic agent10.1016/j.ultsonch.2019.104782 ↗
65. Acoustic super-resolution with ultrasound and microbubbles10.1088/0031-9155/58/18/6447 ↗
66. Effects of the addition of boric acid on the physical properties of MXene/polyvinyl alcohol (PVA) nanocomposite10.1016/j.compositesb.2020.108205 ↗
67. The elastic property of polyvinyl alcohol gel with boric acid as a crosslinking agent10.1002/(SICI)1097-4628(19991220)74:13<3046::AID-APP6>3.0.CO;2-1 ↗
68. Nanobubbles are non-echogenic for fundamental-mode contrast-enhanced ultrasound imaging10.1021/acs.bioconjchem.2c00155 ↗
69. Neutron radiobiology and dosimetry10.1667/RADE-20-00213.1 ↗
70. The origin of neutron biological effectiveness as a function of energy10.1038/srep34033 ↗